- The FDA posted early alerts on November 10 for Arrow wire guide components and Intersurgical breathing tubes, so buyers should check lots on hand.
- A Senate committee bill would raise Indian Health Service funding to $8.40 billion for FY 2027, while the government runs on a stopgap through December 11.
- CMS’s November 9 final rule moves toward country-of-origin reporting for Medicare competitive bidding suppliers ahead of Round 2028.
At a glance
United States
FDA early alerts flag guidewire components, breathing tubes and resuscitators
On November 10 the FDA posted early alerts on Arrow International spring wire guide components, whose hydrophilic coating can clump and detach, and on Intersurgical 22 mm Smoothbore breathing tubes, where too little bonding solvent can let a connector detach and interrupt ventilation. The FDA tells users to stop using and quarantine affected Intersurgical lots, and Intersurgical had reported no serious injuries or deaths as of November 3. The FDA also posted an alert on Compact Medical ButterflyBVM resuscitators on November 3.
Sources: FDA Intersurgical alert · FDA CDRH news · MedTech Dive, Nov. 13, 2026
FDA adds gastric stimulation systems to its device shortage list
The October 26 update added implantable gastric electrical stimulation systems, with an outlook through Q4 2027, and removed angiographic control syringes with rotating adapters. Outlooks for breast biopsy needles, vessel harvesting systems and both oxygenator categories now run through Q1 2027, and neurosurgical sponges through Q4 2026. The FDA lists a component, part or accessory shortage or discontinuance as the reason for every entry.
| Device | FDA outlook | Status |
|---|---|---|
| Neurosurgical patties, sponges and strips | Through Q4 2026 | ▲ In shortage |
| Stereotactic breast biopsy needles | Through Q1 2027 | ▲ In shortage |
| Endoscopic vessel harvesting systems | Through Q1 2027 | ▲ In shortage |
| Oxygenators for cardiopulmonary bypass | Through Q1 2027 | ▲ In shortage |
| Oxygenators for extracorporeal circulation (long-term) | Through Q1 2027 | ▲ In shortage |
| Implantable gastric electrical stimulation systems | Through Q4 2027 (added Oct. 26, 2026) | ▲ In shortage |
| Angiographic control syringes with rotating adapters | Removed Oct. 26, 2026 | ✓ Resolved |
The table shows selected items from the list as updated October 26, 2026. See the FDA Medical Device Shortages List for the complete, current list.
CMS final rule moves toward country-of-origin reporting for competitive bidding suppliers
The calendar year 2027 home health final rule (CMS-1844-F), which also carries DMEPOS policies, says CMS plans to revise an information collection so competitive bidding contract suppliers report the country of origin of the lead items they furnish, with the data shown in the Medicare Supplier Directory. The rule also drops the added face-to-face visit for same-code replacement DMEPOS items and widens grounds for denying or revoking Medicare enrollment. A policy summary says Round 2028 of the bidding program begins January 1, 2028.
Sources: Federal Register · Applied Policy summary, Nov. 4, 2026
No tariff action yet on the Section 232 medical equipment investigation
The Commerce Department’s Section 232 investigation of PPE, medical consumables and medical equipment began September 2, 2025, and the BIS page lists no determination or tariff. Separately, Section 301 forced-labor tariffs took effect July 24, 2026 at 10% for countries such as the EU, India and Mexico and 12.5% for others including China and Vietnam, with exemptions for Section 232 goods and USMCA-qualifying goods.
Sources: BIS · Trade Compliance Resource Hub tariff tracker
Medtronic agrees to buy Contego Medical; Medline holders price a share sale
Medtronic announced on November 16 that it intends to acquire privately held Contego Medical for $380 million plus potential later payments, adding a recently FDA-approved transcarotid revascularization system. On November 17 investors in Medline, including Blackstone, Carlyle and Hellman & Friedman, priced a 60 million-share secondary offering at $35.50, expected to close November 23; Medline gets no proceeds and will repurchase $200 million of shares and units.
Sources: Medtronic · Medline pricing release via Stock Titan
Indian Health Service
Senate committee bill would lift IHS funding to $8.40 billion
The Senate Appropriations Committee released its FY 2027 Interior bill on November 12 with $8.40 billion for IHS, up $353 million from FY 2026, plus $5.39 billion in advance appropriations for FY 2028. NCUIH notes the bill is not expected to become law as written, since the House committee bill carries $8.69 billion and final text must be negotiated. Government funding runs through December 11 under a stopgap, and IHS says programs without advance appropriations, including facilities construction and the electronic health record, operate at a reduced pro-rata rate.
Sources: NCUIH · IHS letter, Sept. 9, 2026
IHS goes live with its new health record and opens a large Arizona clinic
IHS put its PATH electronic health record into use on September 26 at Lawton Indian Hospital and two Oklahoma health centers, the first IHS sites to switch, and reported more than 2,900 patient portal reminders in the first week. The Echo Cliffs Health Center, a 123,000-square-foot outpatient facility in Bodaway Gap, Arizona, opened October 2. IHS also held an October 20 listening session on the Health Care Facilities Construction Priority System.
Sources: IHS press release, Oct. 13, 2026 · IHS update, Oct. 12, 2026
New IHS director in place as the realignment proposal awaits internal approval
HHS announced Mark Cruz as the 12th IHS Director on August 21, 2026. IHS’s realignment page describes the first strategic review in about 20 years, which would turn area offices into 11 area Tribal relations offices and add three Health Care Operations regions, and says the proposal goes through internal approval after consultation that ended in January 2026. IHS’s September and October bulletins carried no dated realignment updates.
Sources: IHS update, Aug. 31, 2026 · IHS realignment page
International
Global device market on track to pass $1 trillion
Fortune Business Insights puts the global medical device market at about $605 billion in 2026, growing 6.9% a year to roughly $1.03 trillion by 2034, with North America holding a 38.1% share in 2025. Other research firms publish different figures, so treat any one forecast as a range.
Source: Fortune Business Insights
China’s revised device GMP is in force; EU registration deadline is November 28
China’s revised medical device GMP took effect November 1, 2026 with no stated grace period. In the EU, November 28, 2026 is the EUDAMED registration deadline for relevant MDR and IVDR devices covered by transitional provisions, while the Commission’s December 2025 proposal to simplify both regulations remains pending, with no Parliament committee vote as of October 5.
Sources: PureGlobal · Complife Group · Deemed Consulting
What to watch
These summaries are written by Osiyo Solutions and link to the original reporting. Verify details with the primary source before acting. This page is general information, not legal, financial or regulatory advice.